What causes hemangiosarcoma? - Environmental Exposures and Canine Cancer Risk

Hemangiosarcoma (HSA) is one of the most aggressive and heartbreaking cancers in dogs, often appearing without warning and spreading rapidly. While new immunotherapy treatments, such as the EGFR/HER2 vaccine, are helping extend survival times, an important question remains: Why are so many dogs developing Hemangiosarcoma? In this webinar, Dr. Catherine Wise, a research scientist at Duke University, will discuss emerging evidence linking chemical exposure to increased cancer risk in dogs. You’ll learn about a new CCA-sponsored study led by Dr Wise and Prof Heather Stapleton, focusing on hemangiosarcoma, which could one day lead to risk-reduction strategies. New immunotherapy treatments are helping canine patients with hemangiosarcoma. 👉 Download FREE Immunotherapy Guide for dogs with cancer: https://ccralliance.myflodesk.com/e-g... ------- About Us The Canine Cancer Alliance (CCA) is a nonprofit foundation that supports research and clinical trials to help dogs with cancer. 👉Learn more about our work https://www.ccralliance.org ❤️Donate here: https://www.ccralliance.org/give **The information in this video is intended for educational and informational purposes only. It should not be considered a substitute for professional veterinary advice. ** #DogCancerTreatment #canineosteosarcoma #pethealth #cancercare #dogcancer #eliascancerimmunotherapy #immunotherapyfordogs